Swantje Held
Swantje Held publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Gastric Cancer Management and Outcomes.
- World rank
- #1,237,063 of 7,710,434 ranked researchers
- Rank in Germany
- #60,951 of 364,343
- Works
- 182
- Citations
- 2.9k
- Citations per work
- 16.0
What does Swantje Held research?
Swantje Held's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences12971.1%
- Medicine12971.1%
- Everything else3217.4%
- Life Sciences2111.5%
- 1Oncology41% of their works
- 2Pulmonary and Respiratory Medicine22% of their works
- 3Cancer Research8% of their works
- 4Pathology and Forensic Medicine4% of their works
- 5Hepatology4% of their works
- 6Molecular Biology3% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Cancer Genomics and Diagnostics
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Genetic factors in colorectal cancer
Which keywords describe Swantje Held's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Targeted Therapy, Clinical Practice Guidelines, Molecular Characterization, ALK Inhibitors and EGFR Mutations.
- Microsatellite Instability
- Liver Cancer
- Surgical Complications
- Rectal Cancer
- Mutational Signatures
- Gastric Cancer
- Adjuvant Chemotherapy
- EGFR Mutations
- Molecular Characterization
- Targeted Therapy
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Clinical Practice Guidelines
- ALK Inhibitors
- Neoadjuvant Therapy
- Endoscopic Resection
- Cancer Genomics
- Preoperative Chemoradiotherapy
- Pancreatic Cancer
- Hepatocellular Carcinoma
- Hereditary Syndromes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Chemotherapy1703 topics
- Cetuximab1121 topic
- KRAS Mutations1121 topic
- Targeted Therapy822 topics
- Clinical Practice Guidelines793 topics
- Molecular Characterization552 topics
- ALK Inhibitors481 topic
- EGFR Mutations481 topic
- Neoadjuvant Therapy422 topics
- Adjuvant Chemotherapy392 topics
- Endoscopic Resection391 topic
- Gastric Cancer391 topic
- Cancer Genomics341 topic
- Mutational Signatures341 topic
- Preoperative Chemoradiotherapy231 topic
- Rectal Cancer231 topic
- Pancreatic Cancer191 topic
- Surgical Complications191 topic
- Hepatocellular Carcinoma171 topic
- Liver Cancer171 topic
- Hereditary Syndromes161 topic
- Microsatellite Instability161 topic
Where does Swantje Held work?
Swantje Held's main affiliation in the publication record is ClinAssess (Germany), Germany.
How many publications and citations does Swantje Held have?
OpenAlex counts 182 works and 2,912 citations for Swantje Held, an h-index of 24, ranking #1,237,063 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Swantje Held. Posts are plain text and can be reported.